Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/25/19
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 06/30/16
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/01/18
End: 01/31/22
Due: 01/31/23
Phase: N/A
Priority: Normal
Start: 10/25/18
End: 12/30/20
Due: 12/30/21
Phase: N/A
Priority: Normal
Start: 11/01/18
End: 01/31/22
Due: 01/31/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| The Impact of Endoscopic Pituitary Surgery on Nasal Function | NCT04018963 | Zhebao Wu | user2@example.com | None | 2019-07-25 | 2021-12-31 | 2022-12-31 | - | - | 2025-07-14 |
| Dopamine Agonists Withdrawal Study of Invasive Prolactinomas Involving the Cavernous Sinus | NCT02536261 | Zhebao Wu | user2@example.com | None | 2016-06-30 | - | - | - | - | 2025-07-14 |
| Dopamine D2 Receptors(D2R) Imaging in Prolactinomas | NCT03717454 | Zhebao Wu | user2@example.com | None | 2018-12-01 | 2022-01-31 | 2023-01-31 | - | - | 2025-07-14 |
| Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas | NCT03400865 | Zhebao Wu | user2@example.com | None | 2018-10-25 | 2020-12-30 | 2021-12-30 | - | - | 2025-07-14 |
| Dopamine D2 Receptors(D2R) Imaging in Nonfunctioning Pituitary Adenoma(NFPA) | NCT03714763 | Zhebao Wu | user2@example.com | None | 2018-11-01 | 2022-01-31 | 2023-01-31 | - | - | 2025-07-14 |